AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
79 hedge funds and large institutions have $107M invested in Agile Therapeutics in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
30% more funds holding
Funds holding: 61 → 79 (+18)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
79
Holding in Top 10
1
Calls
$1.53M
Puts
$497K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$2.78M | |
| 3 | +$2M | |
| 4 |
DCM
DG Capital Management
New York
|
+$1.57M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.41M |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$2.23M | |
| 3 | -$2.12M | |
| 4 |
EP
Eversept Partners
New York
|
-$1.32M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.12M |